Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy

被引：0
|
作者：
Szigiato, Andrei
Mohan, Nitesh
Talcott, Katherine E.
Mammo, Danny A.
Babiuch, Amy S.
Kaiser, Peter K.
Ehlers, Justis P.
Rachitskaya, Aleksandra
Yuan, Alex
Srivastava, Sunil K.
Sharma, Sumit
机构：
来源：
OPHTHALMOLOGY | 2024年 / 131卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：128 / 129
页数：2
相关论文
共 50 条
  • [1] Short-Term Outcomes of Faricimab in Patients with Neovascular Age-Related Macular Degeneration on Prior Anti-VEGF Therapy
    Szigiato, Andrei
    Mohan, Nitesh
    Talcott, Katherine E.
    Mammo, Danny A.
    Babiuch, Amy S.
    Kaiser, Peter K.
    Ehlers, Justis P.
    Rachitskaya, Aleksandra
    Yuan, Alex
    Srivastava, Sunil K.
    Sharma, Sumit
    [J]. OPHTHALMOLOGY RETINA, 2024, 8 (01): : 10 - 17
  • [2] Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration
    Aljundi, Wissam
    Munteanu, Cristian
    Seitz, Berthold
    Abdin, Alaa Din
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (09) : 2867 - 2874
  • [3] Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
    Wykoff, Charles C.
    Clark, W. Lloyd
    Nielsen, Jared S.
    Brill, Joel V.
    Greene, Laurence S.
    Heggen, Cherilyn L.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (02): : S3 - S15
  • [4] Short-term outcomes of intravitreal faricimab for treatment-naive neovascular age-related macular degeneration
    Matsumoto, Hidetaka
    Hoshino, Junki
    Nakamura, Kosuke
    Nagashima, Tetsuhiro
    Akiyama, Hideo
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (10) : 2945 - 2952
  • [5] Epiretinal Membranes in Neovascular Age-Related Macular Degeneration: Effect on Outcomes of Anti-VEGF Therapy
    Karaca, Emine Esra
    Yildiz, Burcin Kepez
    Ozdek, Sengul
    [J]. OPHTHALMOLOGICA, 2014, 232 : 5 - 6
  • [6] Neovascular age-related macular degeneration and anti-VEGF nonresponders
    Sheybani, Arsham
    Almony, Arghavan
    Blinder, Kevin J.
    Shah, Gaurav K.
    [J]. EXPERT REVIEW OF OPHTHALMOLOGY, 2010, 5 (01) : 35 - 41
  • [7] Short-term Outcomes of Faricimab for Neovascular Age-related Macular Degeneration with Limited Response to Ranibizumab or Aflibercept
    Kim, Jeongmin
    Kim, Jae Hui
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2024, 65 (08): : 515 - 524
  • [8] Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: Therapeutic Strategies
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2012, 229 (05) : 541 - 547
  • [9] Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degeneration
    Schneider, Miklos
    Bjerager, Jakob
    Hodzic-Hadzibegovic, Delila
    Klefter, Oliver Niels
    Subhi, Yousif
    Hajari, Javad
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (07) : 2153 - 2162
  • [10] Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography
    Jia, Huixun
    Lu, Bing
    Zhao, Zhi
    Yu, Yang
    Wang, Fenghua
    Zhou, Minwen
    Sun, Xiaodong
    [J]. EYE AND VISION, 2022, 9 (01)
12345